Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.
Department of Nephrology, Ankara City Hospital, Ankara, Turkey.
Blood Purif. 2022;51(9):772-779. doi: 10.1159/000519881. Epub 2021 Nov 23.
There is insufficient data on the role of the medium cutoff (MCO) membranes in the clearance of pro-inflammatory cytokines and oxidant radicals in patients with sepsis requiring hemodialysis.
The study consisted of 38 septic patients who developed acute kidney injury (AKI) and who were scheduled to undergo 2 sessions of hemodialysis. Nineteen patients underwent their first dialysis session with the MCO membrane and 19 patients with the high-flux (HF) membrane. In the second session, the membranes were switched. Pro-inflammatory cytokine and oxidative marker levels were measured in blood samples obtained before and after both dialysis sessions. Reduction ratios were compared for the 2 types of hemodialysis membranes.
After the first session, there was a greater reduction in tumor necrosis factor (TNF)-α with the MCO membrane (28.2 ± 21.1 vs. 8.0 ± 6.6, p = 0.001). After the second session, there was a greater reduction in interleukin (IL)-6 (27.8 ± 26.5 vs. 5.9 ± 13.3, p = 0.003) and IL-1β (20.5 ± 21.1 vs. 4.0 ± 6.5, p = 0.004) with the MCO membrane. When the first and second sessions of all 38 patients were compared, the reductions in TNF-α, IL-6, and IL-1β were consistently greater for MCO than HF (p = 0.001, p = 0.006, p < 0.001, respectively). The reductions in total antioxidant status, total oxidant status, and myeloperoxidase were not statistically different for the 2 types of dialysis membranes.
MCO membrane was superior to HF membrane in the removal of cytokines in septic patients with AKI. However, a similar effect was not observed for oxidative stress markers.
在需要血液透析的脓毒症患者中,关于中分子截止(MCO)膜在清除促炎细胞因子和氧化剂自由基方面的作用,数据不足。
本研究纳入了 38 例发生急性肾损伤(AKI)并计划接受 2 次血液透析的脓毒症患者。19 例患者首次透析采用 MCO 膜,19 例患者采用高通量(HF)膜。在第二次透析中,两种透析膜进行了交换。在两次透析前后,采集血样测量促炎细胞因子和氧化标志物水平。比较两种血液透析膜的降低率。
首次透析后,MCO 膜对肿瘤坏死因子(TNF)-α的降低作用更大(28.2 ± 21.1 比 8.0 ± 6.6,p = 0.001)。第二次透析后,MCO 膜对白细胞介素(IL)-6(27.8 ± 26.5 比 5.9 ± 13.3,p = 0.003)和 IL-1β(20.5 ± 21.1 比 4.0 ± 6.5,p = 0.004)的降低作用更大。比较所有 38 例患者的第一次和第二次透析时,MCO 膜在降低 TNF-α、IL-6 和 IL-1β方面的作用均优于 HF 膜(p = 0.001、p = 0.006、p < 0.001)。两种透析膜对总抗氧化状态、总氧化状态和髓过氧化物酶的降低作用无统计学差异。
在脓毒症合并 AKI 患者中,MCO 膜在清除细胞因子方面优于 HF 膜。然而,对于氧化应激标志物,未观察到类似的效果。